# | Title | Journal | Year | Citations |
---|
1 | Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation | Clinical Therapeutics | 2015 | 437 |
2 | Mast cells: the JEKYLL and HYDE of tumor growth | Trends in Immunology | 2004 | 302 |
3 | Mast cells as targets of corticotropin-releasing factor and related peptides | Trends in Pharmacological Sciences | 2004 | 281 |
4 | MCP-1 and RANTES Are Mediators of Acute and Chronic Inflammation | Allergy and Asthma Proceedings | 2001 | 221 |
5 | IL-10, an inflammatory/inhibitory cytokine, but not always | Immunology Letters | 2003 | 196 |
6 | SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors | Proceedings of the National Academy of Sciences of the United States of America | 2017 | 108 |
7 | Serum Levels of Soluble Adhesion Molecules in Chronic Renal Failure and Dialysis Patients | Nephron | 1998 | 107 |
8 | Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines | European Journal of Pharmacology | 2019 | 99 |
9 | Vascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation | International Journal of Immunopathology and Pharmacology | 2013 | 98 |
10 | IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26 | Immunology Letters | 2003 | 85 |
11 | A comprehensive outlook on intracerebral therapy of malignant gliomas | Critical Reviews in Oncology/Hematology | 2011 | 79 |
12 | Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT release | Immunology | 1995 | 74 |
13 | Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin | Proceedings of the National Academy of Sciences of the United States of America | 2018 | 73 |
14 | Anti‐inflammatory effects of hypoxia‐preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL‐37 | FASEB Journal | 2017 | 68 |
15 | Cytokines in Stress | International Journal of Immunopathology and Pharmacology | 2005 | 65 |
16 | IL-37 (IL-1F7) the Newest Anti-Inflammatory Cytokine Which Suppresses Immune Responses and Inflammation | International Journal of Immunopathology and Pharmacology | 2012 | 64 |
17 | Role of mast cells in tumor growth | Annals of Clinical and Laboratory Science | 2007 | 56 |
18 | Impact of stress and mast cells on brain metastases | Journal of Neuroimmunology | 2008 | 54 |
19 | Environmental and occupational stress and autoimmunity | Autoimmunity Reviews | 2008 | 51 |
20 | Spectrum of mast cell activation disorders | Expert Review of Clinical Immunology | 2014 | 50 |
21 | Nerve Growth Factor Interactions with Mast Cells | International Journal of Immunopathology and Pharmacology | 2014 | 50 |
22 | Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line | Clinical and Experimental Medicine | 2006 | 45 |
23 | Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32) | Autoimmunity Reviews | 2007 | 45 |
24 | IL-1 Superfamily Members and Periodontal Diseases | Journal of Dental Research | 2020 | 44 |
25 | Role of Mast Cells in Atherosclerosis: A Classical Inflammatory Disease | International Journal of Immunopathology and Pharmacology | 2014 | 43 |
26 | The Role of Mast Cells in Alzheimer’s Disease | Advances in Clinical and Experimental Medicine | 2016 | 43 |
27 | Localization of the e-NOS enzyme in endothelial cells and odontoblasts of healthy human dental pulp | Life Sciences | 2000 | 39 |
28 | IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin | Proceedings of the National Academy of Sciences of the United States of America | 2019 | 38 |
29 | Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist | Immunology | 1991 | 38 |
30 | Corticotropin-Releasing Hormone, Microglia and Mental Disorders | International Journal of Immunopathology and Pharmacology | 2014 | 36 |
31 | Endothelial NOS expression and ischemia–reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions | Biochimica Et Biophysica Acta - General Subjects | 2000 | 33 |
32 | Luteolin inhibits mast cell-mediated allergic inflammation | Journal of Biological Regulators and Homeostatic Agents | 2013 | 32 |
33 | Impact of Mast Cells on the Skin | International Journal of Immunopathology and Pharmacology | 2013 | 31 |
34 | Mast Cells May Regulate The Anti-Inflammatory Activity of IL-37 | International Journal of Molecular Sciences | 2019 | 30 |
35 | Nutrition and Cancer Prevention | International Journal of Immunopathology and Pharmacology | 2012 | 29 |
36 | Impact of Capsaicin on Mast Cell Inflammation | International Journal of Immunopathology and Pharmacology | 2013 | 29 |
37 | Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy | Cancer Immunology, Immunotherapy | 2002 | 28 |
38 | IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder | Proceedings of the National Academy of Sciences of the United States of America | 2020 | 28 |
39 | Cytokines and the Brain | International Journal of Immunopathology and Pharmacology | 2004 | 26 |
40 | Interleukin-16 network in inflammation and allergy | Allergy and Asthma Proceedings | 2002 | 26 |
41 | CROSSTALK BETWEEN VITAMIN B AND IMMUNITY | Journal of Biological Regulators and Homeostatic Agents | 2015 | 26 |
42 | Molecular classification of nodal metastasis in primary larynx squamous cell carcinoma | Translational Research | 2007 | 25 |
43 | Autism and Immunity: Revisited Study | International Journal of Immunopathology and Pharmacology | 2009 | 25 |
44 | Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells | Translational Research | 2009 | 25 |
45 | New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators | Journal of Biological Regulators and Homeostatic Agents | 2018 | 25 |
46 | Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferation | Atherosclerosis | 1993 | 24 |
47 | Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37 | European Journal of Pharmacology | 2018 | 24 |
48 | Mechanism by Which Il-16 Generated by Mast Cells Mediates Allergic Inflammation | International Journal of Immunopathology and Pharmacology | 2001 | 23 |
49 | Biology of Neurotensin: Revisited Study | International Journal of Immunopathology and Pharmacology | 2008 | 23 |
50 | Mast Cell Serotonin Immunoregulatory Effects Impacting on Neuronal Function: Implications for Neurodegenerative and Psychiatric Disorders | Neurotoxicity Research | 2015 | 23 |